S La Vignera
Overview
Explore the profile of S La Vignera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
98
Citations
1539
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Calogero A, Duca Y, Condorelli R, La Vignera S
Andrology
. 2017 Oct;
5(6):1064-1072.
PMID: 28992374
The role of urogenital inflammation in causing infertility and sexual dysfunctions has long been a matter of debate in the international scientific literature. The most recent scientific evidences show that...
22.
Condorelli R, Calogero A, DI Mauro M, Mongioi L, Cannarella R, Rosta G, et al.
J Endocrinol Invest
. 2017 Sep;
41(4):383-388.
PMID: 28942551
Background: Insulin resistance is a common feature among women with polycystic ovary syndrome (PCOS), especially in those patients with hyperandrogenism and chronic anovulation. PCOS women are at risk for developing...
23.
Condorelli R, Calogero A, La Vignera S
Acta Physiol (Oxf)
. 2017 Aug;
222(1).
PMID: 28771989
No abstract available.
24.
Condorelli R, La Vignera S, Mongioi L, Vitale S, Lagana A, Cimino L, et al.
Eur Rev Med Pharmacol Sci
. 2017 Jul;
21(2 Suppl):30-35.
PMID: 28724176
Myo-inositol (MYO) usually represents a therapeutic option for female infertility associated with insulin resistance. Recently, several evidences are accumulating about the potential use of MYO for the treatment of male...
25.
Cannarella R, Condorelli R, Mongioi L, La Vignera S, Calogero A
J Endocrinol Invest
. 2017 Jul;
41(1):49-57.
PMID: 28711970
The occurrence of a genetic background in the etiology of polycystic ovarian syndrome (PCOS) represents the rational basis to postulate the existence of a male PCOS equivalent. Hormonal and metabolic...
26.
Tamburino L, La Vignera S, Tomaselli V, Condorelli R, Cannarella R, Mongioi L, et al.
J Assist Reprod Genet
. 2017 Jun;
34(10):1289-1294.
PMID: 28624859
Purpose: The functional role of the FSHR promoter -29G/A polymorphism (rs1394205) in men is not clear. Some studies failed to find a relationship between the FSHR -29G/A and follicle-stimulating hormone...
27.
Calogero A, Aversa A, La Vignera S, Corona G, Ferlin A
J Endocrinol Invest
. 2017 Jun;
40(12):1389-1397.
PMID: 28589384
No abstract available.
28.
Condorelli R, Russo G, Calogero A, Morgia G, La Vignera S
J Endocrinol Invest
. 2017 May;
40(11):1209-1218.
PMID: 28488229
Purpose: Prostatitis is a very common urogenital disease of the male with prevalence ranging from 2.2 to 9.7% worldwide. Interestingly, some recent evidences have showed a significant association between chronic...
29.
Tamburino L, La Vignera S, Tomaselli V, Condorelli R, Mongioi L, Calogero A
J Assist Reprod Genet
. 2017 Mar;
34(5):671-676.
PMID: 28281143
Purpose: The FSHB gene -211G/T polymorphism has been reported to modulate gene expression and to cause inter-individual differences in FSH serum levels in men. This study was undertaken to assess...
30.
La Vignera S, Condorelli R, Mongioi L, Vitale S, Russo G, Lagana A, et al.
Andrologia
. 2016 Nov;
49(8).
PMID: 27882582
Recently, it has been reported that treatment with testosterone (T) could have favourable effects on prostate inflammation; however, the data appear inconsistent. The main evidences concern experimental studies, and there...